HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

Clinical trial NCT05348811 · COMPLETED

Trial details

NCT number: NCT05348811
Sponsor: Zhongda Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma

Start date: 2022-06-13
Primary completion: 2025-10-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.